The Latest Breaking News on Pharma

Gilead Sciences shares rose Friday after the Supreme Court tossed out a challenge that would have impacted HIV PrEP drugs.

President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy. But will it work? And will biotech stocks take a hit?

The world drug market has never been so globalised, active and diverse, according to the United Nations – which marks International Day Against Drug Abuse and Illicit Trafficking on Thursday. RFI takes a look at the latest trends, from the explosion of cocaine to shifting routes and new synthetic drugs.

Biogen said Wednesday its experimental treatment helped children with SMA even after they received an approved gene therapy from Novartis.

Plaintiff says company’s bid to exit bankruptcy omits US government plan to seize $225m that should go to victims

Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug costs and unfairly undermine independent pharmacies

US health secretary faced hours of questioning over budget cuts and accusations he lied to senators

Novo Nordisk ended its partnership with Hims & Hers on 23 June 2025, accusing the telehealth firm of selling unsafe, unapproved Wegovy knock-offs. Hims' stock tanked, and legal risks loom.

CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug, DefenCath.

This medical services stock is in a cup-with-handle base. The biotech's tests detect cancer through blood tests.

The latest shake-up at the FDA forced out the top two officials in charge of reviewing cell and gene therapies, analysts said.